{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T10:38:59Z","timestamp":1776508739387,"version":"3.51.2"},"reference-count":57,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100018291","name":"Koninklijke Belgische Vereniging voor Dermatologie en Venerologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018291","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Targeted biologic drugs and small molecules have transformed the psoriasis treatment landscape in recent years. The Belgian healthcare system, in common with many others across Europe, must balance the burgeoning use of these transformative, yet expensive, drugs with the sustainable use of limited resources. Drawing on recent updates to the EuroGuiDerm and the German S2 psoriasis guidelines, eight Belgian dermatologists experienced in treating patients with psoriasis undertook a quasi\u2010Delphi initiative to provide perspectives on the current opportunities and challenges in psoriasis. This update focuses on responsible ways to rationalize the use of innovative treatments (e.g. biologics and small molecules). Inherently, this required viewpoints on the International Psoriasis Council's new definition of severe psoriasis, defining psoriasis severity and the concept of treating to target. It discusses the appropriateness of using older biologics classes, biosimilars and personalized dosing and lastly, how teledermatology may play a role in providing sustainable, patient\u2010centric psoriasis care. In addition, this manuscript includes the updated Belgian evidence\u2010based treatment advice in psoriasis (BETA\u2010PSO) to reflect recent data and drug approvals. The recommendations reflect the best practices for clinicians when using systemic and biologic therapies to treat patients with psoriasis and offer guidance on how they may prescribe these drugs sustainably and efficiently.<\/jats:p>","DOI":"10.1111\/jdv.20367","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T04:44:37Z","timestamp":1728708277000},"page":"465-475","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Belgian recommendations for managing psoriasis in a changing treatment landscape"],"prefix":"10.1111","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-3546","authenticated-orcid":false,"given":"R.","family":"Speeckaert","sequence":"first","affiliation":[{"name":"Department of Dermatology Ghent University Hospital  Ghent Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. F.","family":"Nikkels","sequence":"additional","affiliation":[{"name":"Department of Dermatology Centre Hospitalier Universitaire de Li\u00e8ge  Li\u00e8ge Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5303-9310","authenticated-orcid":false,"given":"J.","family":"Lambert","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Hospital of Antwerp  Antwerp Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Benhadou","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Erasme Hospital Universit\u00e9 Libre de Bruxelles (ULB)  Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7992-0579","authenticated-orcid":false,"given":"V.","family":"Reynaert","sequence":"additional","affiliation":[{"name":"Department of Dermatology, SKIN Research Group, Vrije Universiteit Brussel (VUB) Universitair Ziekenhuis Brussel (UZ Brussel)  Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. D.","family":"Ghislain","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Cliniques Saint\u2010Luc Universit\u00e9 Catholique de Louvain  Brussels Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4497-8487","authenticated-orcid":false,"given":"T.","family":"Hillary","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Hospital Leuven  Leuven Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L. W.","family":"Lambert","sequence":"additional","affiliation":[{"name":"Department of Dermatology Ghent University Hospital  Ghent Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,10,12]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18333"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.08.026"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16104"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00475-8"},{"key":"e_1_2_10_6_1","unstructured":"British Association of Dermatologists (BAD).Teledermatology.2023Available from:https:\/\/www.bad.org.uk\/clinical\u2010services\/teledermatology\/[Accessed August 2023]"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2018.1561812"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17062008"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-018-3464-4"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-10-251"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2020.94834"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16683"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16684"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16915"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14507"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14508"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-010-1080-1"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13542"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.10.017"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2014.13151"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16564"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1027347"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.9.1175"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00328"},{"key":"e_1_2_10_26_1","first-page":"1","article-title":"Pharmaceutical regulation in 15 European countries review","volume":"18","author":"Panteli D","year":"2016","journal-title":"Health Syst Transit"},{"key":"e_1_2_10_27_1","first-page":"s238","article-title":"Managed care aspects of psoriasis and psoriatic arthritis","volume":"22","author":"Evans C","year":"2016","journal-title":"Am J Manag Care"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2016.04.018"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-067504"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06502.x"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20175603"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2020.100075"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09693.x"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2019.1571500"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-00969-8"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04357.x"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2009.0725"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2023.2214046"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3386"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09944.x"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18112297"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-019-00395-w"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2020.09.006"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-018-0230-9"},{"key":"e_1_2_10_45_1","unstructured":"International Federation of Psoriasis Associations (IPFA).IFPA position statement: Biosimilars. 13 October2021Available from:https:\/\/ifpa\u2010pso.com\/resources\u2010tools\/ifpa\u2010position\u2010statement\u2010on\u2010biosimilars[Accessed September 2023]"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-017-0658-4"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S417922"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2013.10.014"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2016.09.003"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05681-z"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00679-y"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-019-0310-5"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-020-02145-3"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14180"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1258\/135763306776084365"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10509.x"},{"key":"e_1_2_10_57_1","unstructured":"American Telemedicine Association (ATA).Practice guidelines for dermatology.2016Available from:https:\/\/www.americantelemed.org\/resources\/practice\u2010guidelines\u2010for\u2010teledermatology\/[Accessed September 2023]."},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.2196\/11871"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.20367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:42:39Z","timestamp":1760884959000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.20367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,12]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1111\/jdv.20367"],"URL":"https:\/\/doi.org\/10.1111\/jdv.20367","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,12]]},"assertion":[{"value":"2024-02-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}